Ruili Medical & Aesthetic (02135) issued an interim results announcement. Shareholders' losses amounted to RMB 1.617 million, a year-on-year decrease of 28.3%

Zhitongcaijing · 08/30 13:49

According to the Zhitong Finance App, Ruili Medical & Aesthetic (02135) announced results for the six months ended June 30, 2024, with revenue of 117 million yuan (RMB, same below), up 20.4% year on year; parent company owners should have accounted for losses of 1.617 million yuan, a year-on-year decrease of 28.3%; basic loss per share of 0.32 points.

During the reporting period, benefiting from the overall growth space and speed of the medical and aesthetic industry, revenue increased in the first half of the year due to the increase in sales performance of the Group's medical aesthetic device products.